Floatz logo

Therapeutic Asset Ratings

477 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Carboplatin
First-line Treatment
Sun Yat-sen UniversityP2B (60)
Ethiodized Oil
Lenvatinib
Sun Yat-sen UniversityP2B (60)
Golidocitinib
Mature T-cell and NK-cell Lymphoma
Sun Yat-sen UniversityP2B (60)
gsk1120212
Advanced Lung Cancer
Sun Yat-sen UniversityP2B (60)
Irinotecan
Targeted Therapy
Sun Yat-sen UniversityP2B (60)
Tazemetostat
Mature T-cell and NK-cell Lymphoma
Sun Yat-sen UniversityP2B (60)
Theprubicin
Lenvatinib
Sun Yat-sen UniversityP2B (60)
TIPIRACIL
Microsatellite Stable Rectal Carcinoma
Sun Yat-sen UniversityP2B (60)
Toripalimab
Immune Checkpoint Inhibitor
Sun Yat-sen UniversityP2B (60)
Trifluridine
Microsatellite Stable Rectal Carcinoma
Sun Yat-sen UniversityP2B (60)
Tucidinostat
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Sun Yat-sen UniversityP2B (60)
(+)-VINCRISTINE
Targeted Therapy
Sun Yat-sen UniversityP2B (60)
Capecitabine
Peritoneal Cancer
Sun Yat-sen UniversityP2/3B (60)
Capecitabine
Peritoneal Neoplasms
Sun Yat-sen UniversityP2/3B (60)
Fruquintinib
Advanced Renal Cell Carcinoma
Sun Yat-sen UniversityP2/3B (60)
Capmatinib
Carcinoma, Non-Small-Cell Lung
Sun Yat-sen UniversityP4B (59)
Theprubicin
Liver Cancer
Sun Yat-sen UniversityP4B (59)
Entecavir
B-cell Lymphoma
Sun Yat-sen UniversityP3B (59)
LENVATINIB
Neoadjuvant Therapy
Sun Yat-sen UniversityP3B (59)
Pucotenlimab
Colorectal Cancer (CRC)
Sun Yat-sen UniversityP3B (59)
Pucotenlimab
Rectal Adenocarcinoma
Sun Yat-sen UniversityP3B (59)
Pucotenlimab
Rectal Cancer
Sun Yat-sen UniversityP3B (59)
Calcium folinate pentahydrate
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-sen UniversityP3B (58)
Eloxatin
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-sen UniversityP3B (58)
MOXIFLOXACIN
Breast Cancer
Sun Yat-sen UniversityP3B (58)
Showing 76 to 100 of 477 assets
PreviousPage 4 of 20Next